Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 121

1.

The Impact of a Junior Faculty Fellowship Award on Academic Advancement and Retention.

Connelly MT, Sullivan AM, Chinchilla M, Dale ML, Emans SJ, Nadelson CC, Notman MT, Tarbell NJ, Zigler CM, Shore EG.

Acad Med. 2016 Dec 27. doi: 10.1097/ACM.0000000000001541. [Epub ahead of print]

PMID:
28030418
2.

Improving Resident Communication in the Intensive Care Unit. The Proceduralization of Physician Communication with Patients and Their Surrogates.

Miller DC, McSparron JI, Clardy PF, Sullivan AM, Hayes MM.

Ann Am Thorac Soc. 2016 Sep;13(9):1624-8. doi: 10.1513/AnnalsATS.201601-029PS.

PMID:
27374415
3.

Distinct alterations in motor & reward seeking behavior are dependent on the gestational age of exposure to LPS-induced maternal immune activation.

Straley ME, Van Oeffelen W, Theze S, Sullivan AM, O'Mahony SM, Cryan JF, O'Keeffe GW.

Brain Behav Immun. 2016 Jun 4. pii: S0889-1591(16)30151-9. doi: 10.1016/j.bbi.2016.06.002. [Epub ahead of print]

PMID:
27266391
4.

A Small Molecule Activator of p300/CBP Histone Acetyltransferase Promotes Survival and Neurite Growth in a Cellular Model of Parkinson's Disease.

Hegarty SV, O'Leary E, Solger F, Stanicka J, Sullivan AM, O'Keeffe GW.

Neurotox Res. 2016 Oct;30(3):510-20. doi: 10.1007/s12640-016-9636-2.

PMID:
27256286
5.

Neurotrophic factor therapy for Parkinson's disease: past, present and future.

Sullivan AM, O'Keeffe GW.

Neural Regen Res. 2016 Feb;11(2):205-7. doi: 10.4103/1673-5374.177710. No abstract available.

6.

Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms.

Felice VD, Quigley EM, Sullivan AM, O'Keeffe GW, O'Mahony SM.

Parkinsonism Relat Disord. 2016 Jun;27:1-8. doi: 10.1016/j.parkreldis.2016.03.012. Review.

PMID:
27013171
7.

A Nephrology Fellows' Communication Skills Course: An Educational Quality Improvement Report.

Cohen RA, Jackson VA, Norwich D, Schell JO, Schaefer K, Ship AN, Sullivan AM.

Am J Kidney Dis. 2016 Aug;68(2):203-11. doi: 10.1053/j.ajkd.2016.01.025.

PMID:
26994686
8.

The Impact of Resident Training on Communication with Families in the Intensive Care Unit. Resident and Family Outcomes.

Sullivan AM, Rock LK, Gadmer NM, Norwich DE, Schwartzstein RM.

Ann Am Thorac Soc. 2016 Apr;13(4):512-21. doi: 10.1513/AnnalsATS.201508-495OC.

PMID:
26989925
9.

A multi-site study of strategies to teach critical thinking: 'why do you think that?'.

Huang GC, Lindell D, Jaffe LE, Sullivan AM.

Med Educ. 2016 Feb;50(2):236-49. doi: 10.1111/medu.12937.

PMID:
26813002
10.

Nociceptin/Orphanin FQ Inhibits the Survival and Axon Growth of Midbrain Dopaminergic Neurons Through a p38-MAPK Dependent Mechanism.

Collins LM, Dal Bo G, Calcagno M, Monzón-Sandoval J, Sullivan AM, Gutierrez H, Morari M, O'Keeffe GW.

Mol Neurobiol. 2016 Dec;53(10):7284-7297.

PMID:
26687234
11.

Assessing the Effectiveness of Case-Based Collaborative Learning via Randomized Controlled Trial.

Krupat E, Richards JB, Sullivan AM, Fleenor TJ Jr, Schwartzstein RM.

Acad Med. 2016 May;91(5):723-9. doi: 10.1097/ACM.0000000000001004.

PMID:
26606719
12.

Zeb2: A multifunctional regulator of nervous system development.

Hegarty SV, Sullivan AM, O'Keeffe GW.

Prog Neurobiol. 2015 Sep;132:81-95. doi: 10.1016/j.pneurobio.2015.07.001. Review.

PMID:
26193487
13.

Teaching during consultation: factors affecting the resident-fellow teaching interaction.

Miloslavsky EM, McSparron JI, Richards JB, Puig A, Sullivan AM.

Med Educ. 2015 Jul;49(7):717-30. doi: 10.1111/medu.12760.

PMID:
26077219
14.

Bruton's Tyrosine Kinase Synergizes with Notch2 To Govern Marginal Zone B Cells in Nonobese Diabetic Mice.

Case JB, Bonami RH, Nyhoff LE, Steinberg HE, Sullivan AM, Kendall PL.

J Immunol. 2015 Jul 1;195(1):61-70. doi: 10.4049/jimmunol.1400803.

15.

Viral vector delivery of neurotrophic factors for Parkinson's disease therapy.

Kelly MJ, O'Keeffe GW, Sullivan AM.

Expert Rev Mol Med. 2015 May 13;17:e8. doi: 10.1017/erm.2015.6. Review.

PMID:
25997719
16.

Neurotrophic factors: from neurodevelopmental regulators to novel therapies for Parkinson's disease.

Hegarty SV, O'Keeffe GW, Sullivan AM.

Neural Regen Res. 2014 Oct 1;9(19):1708-11. doi: 10.4103/1673-5374.143410. Review.

17.

Mapping and dynamics of regulatory DNA and transcription factor networks in A. thaliana.

Sullivan AM, Arsovski AA, Lempe J, Bubb KL, Weirauch MT, Sabo PJ, Sandstrom R, Thurman RE, Neph S, Reynolds AP, Stergachis AB, Vernot B, Johnson AK, Haugen E, Sullivan ST, Thompson A, Neri FV 3rd, Weaver M, Diegel M, Mnaimneh S, Yang A, Hughes TR, Nemhauser JL, Queitsch C, Stamatoyannopoulos JA.

Cell Rep. 2014 Sep 25;8(6):2015-30. doi: 10.1016/j.celrep.2014.08.019.

18.

Class-IIa Histone Deacetylase Inhibition Promotes the Growth of Neural Processes and Protects Them Against Neurotoxic Insult.

Collins LM, Adriaanse LJ, Theratile SD, Hegarty SV, Sullivan AM, O'Keeffe GW.

Mol Neurobiol. 2015;51(3):1432-42. doi: 10.1007/s12035-014-8820-8.

PMID:
25065734
19.

Raising the bar for the care of seriously ill patients: results of a national survey to define essential palliative care competencies for medical students and residents.

Schaefer KG, Chittenden EH, Sullivan AM, Periyakoil VS, Morrison LJ, Carey EC, Sanchez-Reilly S, Block SD.

Acad Med. 2014 Jul;89(7):1024-31. doi: 10.1097/ACM.0000000000000271.

20.

Expression of endogenous Mkp1 in 6-OHDA rat models of Parkinson's disease.

Collins LM, Gavin AM, Walsh S, Sullivan AM, Wyatt SL, O'Keeffe GW, Nolan YM, Toulouse A.

Springerplus. 2014 Apr 28;3:205. doi: 10.1186/2193-1801-3-205.

Items per page

Supplemental Content

Loading ...
Support Center